The Injury and Therapy of Reactive Oxygen Species in Intracerebral Hemorrhage Looking at Mitochondria

Intracerebral hemorrhage is an emerging major health problem often resulting in death or disability. Reactive oxygen species (ROS) have been identified as one of the major damaging factors in ischemic stroke. However, there is less discussion about ROS in hemorrhage stroke. Metabolic products of hem...

Full description

Bibliographic Details
Main Authors: Jie Qu, Weixiang Chen, Rong Hu, Hua Feng
Format: Article
Language:English
Published: Hindawi Limited 2016-01-01
Series:Oxidative Medicine and Cellular Longevity
Online Access:http://dx.doi.org/10.1155/2016/2592935
id doaj-0cdd0144abf8423d81c269da93b8d021
record_format Article
spelling doaj-0cdd0144abf8423d81c269da93b8d0212020-11-24T23:55:12ZengHindawi LimitedOxidative Medicine and Cellular Longevity1942-09001942-09942016-01-01201610.1155/2016/25929352592935The Injury and Therapy of Reactive Oxygen Species in Intracerebral Hemorrhage Looking at MitochondriaJie Qu0Weixiang Chen1Rong Hu2Hua Feng3Department of Neurosurgery, Southwest Hospital, Third Military Medical University, No. 30, Gaotanyan Street, Chongqing 400038, ChinaDepartment of Neurosurgery, Southwest Hospital, Third Military Medical University, No. 30, Gaotanyan Street, Chongqing 400038, ChinaDepartment of Neurosurgery, Southwest Hospital, Third Military Medical University, No. 30, Gaotanyan Street, Chongqing 400038, ChinaDepartment of Neurosurgery, Southwest Hospital, Third Military Medical University, No. 30, Gaotanyan Street, Chongqing 400038, ChinaIntracerebral hemorrhage is an emerging major health problem often resulting in death or disability. Reactive oxygen species (ROS) have been identified as one of the major damaging factors in ischemic stroke. However, there is less discussion about ROS in hemorrhage stroke. Metabolic products of hemoglobin, excitatory amino acids, and inflammatory cells are all sources of ROS, and ROS harm the central nervous system through cell death and structural damage, especially disruption of the blood-brain barrier. We have considered the antioxidant system of the CNS itself and the drugs aiming to decrease ROS after ICH, and we find that mitochondria are key players in all of these aspects. Moreover, when the mitochondrial permeability transition pore opens, ROS-induced ROS release, which leads to extensive liberation of ROS and mitochondrial failure, occurs. Therefore, the mitochondrion may be a significant target for elucidating the problem of ROS in ICH; however, additional experimental support is required.http://dx.doi.org/10.1155/2016/2592935
collection DOAJ
language English
format Article
sources DOAJ
author Jie Qu
Weixiang Chen
Rong Hu
Hua Feng
spellingShingle Jie Qu
Weixiang Chen
Rong Hu
Hua Feng
The Injury and Therapy of Reactive Oxygen Species in Intracerebral Hemorrhage Looking at Mitochondria
Oxidative Medicine and Cellular Longevity
author_facet Jie Qu
Weixiang Chen
Rong Hu
Hua Feng
author_sort Jie Qu
title The Injury and Therapy of Reactive Oxygen Species in Intracerebral Hemorrhage Looking at Mitochondria
title_short The Injury and Therapy of Reactive Oxygen Species in Intracerebral Hemorrhage Looking at Mitochondria
title_full The Injury and Therapy of Reactive Oxygen Species in Intracerebral Hemorrhage Looking at Mitochondria
title_fullStr The Injury and Therapy of Reactive Oxygen Species in Intracerebral Hemorrhage Looking at Mitochondria
title_full_unstemmed The Injury and Therapy of Reactive Oxygen Species in Intracerebral Hemorrhage Looking at Mitochondria
title_sort injury and therapy of reactive oxygen species in intracerebral hemorrhage looking at mitochondria
publisher Hindawi Limited
series Oxidative Medicine and Cellular Longevity
issn 1942-0900
1942-0994
publishDate 2016-01-01
description Intracerebral hemorrhage is an emerging major health problem often resulting in death or disability. Reactive oxygen species (ROS) have been identified as one of the major damaging factors in ischemic stroke. However, there is less discussion about ROS in hemorrhage stroke. Metabolic products of hemoglobin, excitatory amino acids, and inflammatory cells are all sources of ROS, and ROS harm the central nervous system through cell death and structural damage, especially disruption of the blood-brain barrier. We have considered the antioxidant system of the CNS itself and the drugs aiming to decrease ROS after ICH, and we find that mitochondria are key players in all of these aspects. Moreover, when the mitochondrial permeability transition pore opens, ROS-induced ROS release, which leads to extensive liberation of ROS and mitochondrial failure, occurs. Therefore, the mitochondrion may be a significant target for elucidating the problem of ROS in ICH; however, additional experimental support is required.
url http://dx.doi.org/10.1155/2016/2592935
work_keys_str_mv AT jiequ theinjuryandtherapyofreactiveoxygenspeciesinintracerebralhemorrhagelookingatmitochondria
AT weixiangchen theinjuryandtherapyofreactiveoxygenspeciesinintracerebralhemorrhagelookingatmitochondria
AT ronghu theinjuryandtherapyofreactiveoxygenspeciesinintracerebralhemorrhagelookingatmitochondria
AT huafeng theinjuryandtherapyofreactiveoxygenspeciesinintracerebralhemorrhagelookingatmitochondria
AT jiequ injuryandtherapyofreactiveoxygenspeciesinintracerebralhemorrhagelookingatmitochondria
AT weixiangchen injuryandtherapyofreactiveoxygenspeciesinintracerebralhemorrhagelookingatmitochondria
AT ronghu injuryandtherapyofreactiveoxygenspeciesinintracerebralhemorrhagelookingatmitochondria
AT huafeng injuryandtherapyofreactiveoxygenspeciesinintracerebralhemorrhagelookingatmitochondria
_version_ 1725463663910846464